Neosplice Therapeutics, Inc.
New York, NY
- UEI
- ZJHHBAXNB7B8
- CAGE
- Not on record
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- Silver Towers, 110 Bleecker St #20b, New York, NY 10012, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Proteogenomic discovery engine for exposing the exposed: splice surface therapeutic targets | National Center for Advancing Translational Sciences (NIH) | $321,316 |
Quick answers
Is Neosplice Therapeutics, Inc. registered in SAM.gov?
Yes. Neosplice Therapeutics, Inc.'s SAM.gov registration is active through May 14, 2027.
What is Neosplice Therapeutics, Inc.'s most recent federal award?
Neosplice Therapeutics, Inc.'s most recent federal grant award is Proteogenomic discovery engine for exposing the exposed: splice surface therapeutic targets (R41TR006343), from National Center for Advancing Translational Sciences (NIH), on July 20, 2026.
On GovTribe
See Neosplice Therapeutics, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors